For anyone interested in learning more about partial reprogramming, I recently wrote a review article on the current state of the art: https://www.adanguyenx.com/blog/partial-reprogramming In short, we're still far away…
There are currently 9 companies working on this, and none are in clinical trials yet. The closest is turn.bio, which is expected to enter clinical trial late this year. So we're 10+ years away from seeing this in…
For anyone interested in learning more about partial reprogramming, I recently wrote a review article on the current state of the art: https://www.adanguyenx.com/blog/partial-reprogramming In short, we're still far away…
There are currently 9 companies working on this, and none are in clinical trials yet. The closest is turn.bio, which is expected to enter clinical trial late this year. So we're 10+ years away from seeing this in…